KMT2A and acute myeloid leukemia: Both entities are associated with infant AML or t-AML, extramedullary disease, and monocytic/monoblastic or myelomonocytic differentiation, and they may be related to the important roles that the MYST3::CREBBP and KMT2A fusion genes play in histone modification [8].